Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Rheumatic Diseases Clinics of North America|April 26, 2024
De novo Connective Tissue Disorders as Immune-related Adverse EventsLindsay Kristin Cho, Shahin JamalThe Journal of Rheumatology|November 3, 2010
Biologic therapy for systemic sclerosis: a systematic reviewVeerapong Phumethum, Shahin Jamal, Sindhu R JohnsonClinical Rheumatology|December 11, 2008
Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysisShahin Jamal, Kaushik Patra, Edward C KeystoneJournal of Immunotherapy (Hagerstown, Md. : 1997)|May 20, 2024
False-positive Findings of Large Vessel Vasculitis on FDG-PET in Patients Treated With Immune Checkpoint InhibitorsDylan Johnson, Shahin Jamal, Ryan W Hung, et al.The Journal of Rheumatology|July 17, 2019
Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing RheumatologistShahin Jamal, Marie Hudson, Aurore Fifi-Mah, et al.Pediatric Rheumatology Online Journal|July 15, 2025
Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessmentJohn Storwick, Carrie Ye, Shahin Jamal, et al.The Journal of Rheumatology|May 17, 2011
Time to treatment for new patients with rheumatoid arthritis in a major metropolitan cityShahin Jamal, Shabbir M H Alibhai, Elizabeth M Badley, et al.Rheumatology and Therapy|October 30, 2018
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional StudyBoulos Haraoui, Shahin Jamal, Vandana Ahluwalia, et al.Health & Social Care in the Community|September 7, 2018
Internet health scams-Developing a taxonomy and risk-of-deception assessment toolBernie Garrett, Sue Murphy, Shahin Jamal, et al.Cell Reports. Medicine|April 26, 2021
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndromeLuke Y C Chen, Catherine M Biggs, Shahin Jamal, et al.Pageof 5